Vaxart Other Operating Expenses from 2010 to 2025
| VXRT Stock | USD 0.74 0.03 3.90% |
Other Operating Expenses | First Reported 1985-12-31 | Previous Quarter 22.7 M | Current Value 19.4 M | Quarterly Volatility 20.8 M |
Check Vaxart financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Vaxart's main balance sheet or income statement drivers, such as Depreciation And Amortization of 8.1 M, Interest Expense of 1.4 M or Total Revenue of 6.3 M, as well as many indicators such as Price To Sales Ratio of 9.61, Dividend Yield of 0.0 or PTB Ratio of 2.34. Vaxart financial statements analysis is a perfect complement when working with Vaxart Valuation or Volatility modules.
Vaxart | Other Operating Expenses |
Latest Vaxart's Other Operating Expenses Growth Pattern
Below is the plot of the Other Operating Expenses of Vaxart Inc over the last few years. Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Vaxart Inc. It is also known as Vaxart overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. It is expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production. Vaxart's Other Operating Expenses historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Vaxart's overall financial position and show how it may be relating to other accounts over time.
| Other Operating Expenses | 10 Years Trend |
|
Other Operating Expenses |
| Timeline |
Vaxart Other Operating Expenses Regression Statistics
| Arithmetic Mean | 53,423,413 | |
| Geometric Mean | 46,947,269 | |
| Coefficient Of Variation | 51.83 | |
| Mean Deviation | 23,435,766 | |
| Median | 53,200,000 | |
| Standard Deviation | 27,691,279 | |
| Sample Variance | 766.8T | |
| Range | 89.7M | |
| R-Value | 0.56 | |
| Mean Square Error | 563.1T | |
| R-Squared | 0.31 | |
| Significance | 0.02 | |
| Slope | 3,262,203 | |
| Total Sum of Squares | 11502.1T |
Vaxart Other Operating Expenses History
About Vaxart Financial Statements
Vaxart shareholders use historical fundamental indicators, such as Other Operating Expenses, to determine how well the company is positioned to perform in the future. Although Vaxart investors may analyze each financial statement separately, they are all interrelated. The changes in Vaxart's assets and liabilities, for example, are also reflected in the revenues and expenses on on Vaxart's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Other Operating Expenses | 81.7 M | 75.8 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Vaxart Stock Analysis
When running Vaxart's price analysis, check to measure Vaxart's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxart is operating at the current time. Most of Vaxart's value examination focuses on studying past and present price action to predict the probability of Vaxart's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxart's price. Additionally, you may evaluate how the addition of Vaxart to your portfolios can decrease your overall portfolio volatility.